-+ 0.00%
-+ 0.00%
-+ 0.00%
Sihuan Pharmaceutical (00460): Shuiguang Acupuncture (trade name: Dong Yan) was approved for listing with the new specifications by the State Drug Administration
Share
Listen to the news

Zhitong Finance App News, Sihuan Pharmaceutical (00460) announced that five new specifications of the injectable sodium hyaluronate complex solution (water light needle or this product, product name: Dong Yan) independently developed by the Group's subsidiary, have been officially approved for listing by China's National Drug Administration. This new specification was approved as an important development since the product was launched, further consolidating the Group's product layout and competitiveness at the Light Medical and Aesthetic Water Light Circuit.

As the first compound solution containing L-carnosine in China for direct use on the face, Dongyan's core ingredients include active ingredients such as hyaluronic acid, L-carnosine, various amino acids and vitamin B2. It has multiple effects such as hydrating, moisturizing, anti-oxidation, anti-sugar, anti-inflammatory, and promoting collagen regeneration. It is used for injection into the facial dermal layer to effectively improve dry skin and dull skin tone. It is suitable for popular light medical and aesthetic skin care needs, covering a wide range of consumer groups. Prior to this specification expansion, the product had been approved, including seven specifications: 0.5mL/stick, 1.0mL/ stick, 1.5mL/ stick, 2.0mL/ stick, 2.5mL/ stick, 5mL/ box (containing 2 2.5mL/stick); five additional specifications were approved this time: 0.75mL/stick, 1.75mL/stick, 2.25mL/stick, 2.75mL/ stick, 2.75mL/ branch, 2.75mL/ branch, and 2.75mL/ branch, effectively filling the gaps in the dosage range of the original product, forming a complete and comprehensive product dosage spectrum.

The main value and significance of this specification addition:

1. Adapt to diverse skin needs and enrich clinical application scenarios: The new specifications make up for the gaps in the dosage range of the original product, and can be adapted to various types of clinical scenarios such as superficial partial care, basic full face care, and combined regenerative filling treatment. In response to different facial care areas, dull skin conditions and differences in individual consumer tolerance, clinicians are provided with more detailed dosage options, which can better match the personalized skin improvement needs of consumers of different age groups and skin conditions.

2. Improve product matrix construction and strengthen racetrack synergy advantages: As the core category of light medicine and beauty, water light products have the characteristics of broad market space and outstanding user repurchase attributes. The domestic light medicine and aesthetic water light segment continues to develop steadily, and industry consumption and clinical needs are gradually being upgraded in the direction of standardization and individualization. With the full implementation of Dong Yeon's full-gradient dosage product matrix, it is possible to strengthen business collaboration with different product categories such as botulinum toxin, baby acupuncture, girls' acupuncture, and gold microneedle, and flexibly combine them to form a “filling regeneration+skin quality repair” joint anti-aging solution. It will rely on a mature marketing channel network covering more than 370 cities across the country and cooperating with more than 9,000 medical institutions to further consolidate the full operating advantages and market competitiveness of the beauty space in the light medical and aesthetic sector.

3. Help the industry develop in a standardized and refined manner: With the continuous upgrading of domestic medical and aesthetic consumption concepts, industry services have gradually moved from traditional models to customized and differentiated personalized treatment plans. The approval and listing of the gradient dosage specification can provide an effective reference for the specification development and product iteration of similar hydrophotometry Class III medical devices in China, and help promote the high-quality and refined development of the industry.

Qiyan Space is a “one-stop” new medical and aesthetic platform for Sihuan Pharmaceutical to carefully incubate. Through a global layout, a comprehensive and professional medical and aesthetic product matrix, and an integrated structure for product R&D, registration, production and sales, it is committed to building a leading enterprise in the entire Chinese medical and aesthetic product matrix with ingenuity through the strict innovation of pharmaceutical companies. Beauty Space continues to create a complete product matrix covering the entire life cycle needs of beauty lovers through the “self-development+BD” dual engine drive. The pipeline includes more than 60 products, covering basic categories of light medicine and beauty, including filling, shaping, support, optoelectronic equipment, and skin care. At the same time, Beauty Space has strong independent R&D and technological transformation capabilities, and its professional BD teams and R&D teams at home and abroad can quickly promote the development and implementation of medical and aesthetic products. Currently, Yuyan Space has established three production bases around the world, has a perfect quality management system, and implements effective risk management throughout the product life cycle. Its experienced medical and aesthetic sales team, extensive nationwide sales network and deep development system can rapidly advance product sales. Most of the sales team members of Beauty Space come from multinational medical, aesthetic and pharmaceutical companies. They have rich sales experience in medical and aesthetic products, and work closely with dozens of agents. The sales network has covered more than 370 cities and more than 9,000 medical and aesthetic institutions across the country.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending